Navigation Links
The Cloudburst Group Appoints Pat Shifflett as Vice-President, Health Practice
Date:4/2/2008

- Industry Leader to Join 8(a) Consulting Firm -

LANDOVER, Md., April 2, 2008 /PRNewswire/ -- The Cloudburst Group today announced that Pat Shifflett, an industry leader in public health strategic planning and program development, will join the firm as Vice-President of its Health Practice. In this newly created position, Shifflett will open Cloudburst's Atlanta office and will be responsible for managing and driving the firm's growing business in health communications, program planning and technical assistance services.

"Pat has a twenty-year track record of success in health communications and program planning and development," said Al Alvarez, Cloudburst's President and CEO. "She is the ideal person to build the Cloudburst business, and tell the Cloudburst story to public and private sector health professionals."

Shifflett joins Cloudburst from Constella Health Sciences, where she has spent the last six years building and managing Constella's Center for Health Program Advancement, focusing primarily on federal, state and public health organizations, including the Centers for Disease Control. Prior to joining Constella, Shifflett was the Director of Patient and Family Support at the American Cancer Society. Shifflett has been recognized by her peers as an industry leader, winning the CINE Golden Eagle Award for the CDC "Just Talk" Public Service Announcement as well as the PRSA Silver Anvil Award for the American Cancer Society's "Tell-A-Friend" campaign.

Shifflett is a graduate of the Westminister College of Nursing and holds a Master's degree from the Capella University School of Business.

About The Cloudburst Group

The Cloudburst Consulting Group, Inc. is a small, disadvantaged 8(a) firm established in 2005 and headquartered in Landover, Maryland. Cloudburst is composed of experienced professionals who work with public and private organizations, both domestically and internationally, to enhance the impa
'/>"/>

SOURCE The Cloudburst Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Broad-based group of physicians calls for improvement in stroke treatment
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
4. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
5. New Research Uncovers how to Build and Maintain an Effective Competitive Intelligence Group
6. AMERIGROUP to Acquire Memphis Health Plan
7. Securians Minnesota Life Continues to Climb Group Life Rankings
8. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
9. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
10. Group B Strep: A Threat to Newborns That Doesnt Have to Be
11. Cynosure to Present at the Maxim Group Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Stress May Raise Diabetes Risk for Obese Black Women 2Health News:NBC Digital Health Network Upgrades WEGENER(R) Compel(R) Network Control System and Adds MediaPlan(R) Content Management System 2Health News:NBC Digital Health Network Upgrades WEGENER(R) Compel(R) Network Control System and Adds MediaPlan(R) Content Management System 3Health News:NBC Digital Health Network Upgrades WEGENER(R) Compel(R) Network Control System and Adds MediaPlan(R) Content Management System 4Health News:NBC Digital Health Network Upgrades WEGENER(R) Compel(R) Network Control System and Adds MediaPlan(R) Content Management System 5Health News:InfoLogix Implements Wireless Multi-Site Medical Communications Solution for Sisters of Mercy Health System 2Health News:InfoLogix Implements Wireless Multi-Site Medical Communications Solution for Sisters of Mercy Health System 3Health News:InfoLogix Implements Wireless Multi-Site Medical Communications Solution for Sisters of Mercy Health System 4Health News:InfoLogix Implements Wireless Multi-Site Medical Communications Solution for Sisters of Mercy Health System 5Health News:Medifast, Inc. Announces Appointment of Two Additional Independent Board Members 2Health News:Medifast, Inc. Announces Appointment of Two Additional Independent Board Members 3Health News:Medifast, Inc. Announces Appointment of Two Additional Independent Board Members 4Health News:UT School of Public Health Program to Prevent Childhood Obesity Expands to Central Texas Middle Schools 2Health News:UT School of Public Health Program to Prevent Childhood Obesity Expands to Central Texas Middle Schools 3Health News:UT School of Public Health Program to Prevent Childhood Obesity Expands to Central Texas Middle Schools 4
Breaking Medicine Technology:Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 2Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 3Free Wheelchair Mission Breaks List of Top 60 OC Nonprofits in 2009 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6L A Zoo Announces Successful Cancer Treatment of Rhinoceros With Electronic Brachytherapy 6309 1L A Zoo Announces Successful Cancer Treatment of Rhinoceros With Electronic Brachytherapy 6309 2L A Zoo Announces Successful Cancer Treatment of Rhinoceros With Electronic Brachytherapy 6309 3Par Pharmaceutical to Host Analyst Day on December 3rd 6307 1NeurogesX Receives FDA Approval of Qutenza 28TM 29 28capsaicin 29 8 25 Patch for Treatment of Postherpetic Neuralgia 28PHN 29 6305 1NeurogesX Receives FDA Approval of Qutenza 28TM 29 28capsaicin 29 8 25 Patch for Treatment of Postherpetic Neuralgia 28PHN 29 6305 2NeurogesX Receives FDA Approval of Qutenza 28TM 29 28capsaicin 29 8 25 Patch for Treatment of Postherpetic Neuralgia 28PHN 29 6305 3NeurogesX Receives FDA Approval of Qutenza 28TM 29 28capsaicin 29 8 25 Patch for Treatment of Postherpetic Neuralgia 28PHN 29 6305 4NeurogesX Receives FDA Approval of Qutenza 28TM 29 28capsaicin 29 8 25 Patch for Treatment of Postherpetic Neuralgia 28PHN 29 6305 5